New Gastroenterology Study Findings Recently Were Published by a Researcher at University of Texas MD Anderson Cancer Center (Practice Changes in Checkpoint Inhibitor-Induced Immune-Related Adverse Event Management at a Tertiary Care Center).

Předmět:
Zdroj: Cardiovascular Week; 1/29/2024, p436-436, 1p
Abstrakt: A recent study conducted at the University of Texas MD Anderson Cancer Center examined changes in the management of immune-related adverse events (irAEs) caused by checkpoint inhibitors. The study found that outpatient treatment and earlier specialty consultation led to improved outcomes for gastrointestinal irAEs. However, follow-up rates after hospital discharge remained consistently low. The findings of this study can help inform the development of management algorithms and policies in other institutions. [Extracted from the article]
Databáze: Complementary Index